NRXP logo
NRXP NASDAQ US

NRX Pharmaceuticals, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Nov 2017
$2.20
▲ +$0.04 (+1.85%)
Vol 355K
2
Quality Score
fail
Mkt Cap
$80.2M
ROE
-195.8%
D/E
142.06
Beta
1.94
52W
$1–$6

Wall Street Consensus

10 analysts · Apr 2026
3
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Similar Stocks

PLRX
Pliant Therapeutics Inc
$75.0M
GRCE
Grace Therapeutics, Inc
$53.5M
CGTX
Cognition Therapeutics Inc
$119.2M
CING
Cingulate Inc
$29.3M
SCLX
Scilex Holding Co
$103.6M

Earnings

Beat rate: 20.0%
Next Report May 13, 2026
EPS Estimate: $-0.04
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.04 — —
Dec 2025 $0.00 $-0.01 $-0.01
Sep 2025 $-0.09 $-0.50 $-0.41
Jun 2025 $-0.21 $-0.31 $-0.10

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -195.8% -195.8% -195.8% -195.8% -195.8%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio — 142.06 142.06 142.06 142.06 142.06
Current Ratio 0.11 0.22 0.11 0.11 0.11 0.29

Key Ratios

ROA (TTM)
-489.9%
P/B
10.1
EPS (TTM)
$-2.32
CF/Share
$-0.50
52W High
$6.01
52W Low
$1.41
$1.41 52-Week Range $6.01

How does NRXP compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

NRXP AARD ACB ACRS ADIL

NRXP valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
10.1
▲ 378% above peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

NRXP profitability vs Pharmaceuticals peers

ROE
-195.8%
▼ 261% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-489.9%
▼ 1209% below peers (-37.4%)
vs Peers
vs Industry
Weak

NRXP financial health vs Pharmaceuticals peers

D/E ratio
142.1
▲ 9125% above peers (1.5)
vs Peers
vs Industry
High debt
Current ratio
0.3
▼ 91% below peers (3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.9
▲ 106% above peers (0.9)
vs Peers
vs Industry
More volatile

NRXP fundamentals radar

NRXP Peer median Industry

NRXP profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

NRXP vs peers: key metrics

Latest News

NRx Pharmaceuticals Wraps Virtual Annual Meeting, Eyes Pivotal 2025 Earnings Call Ahead
Yahoo Finance · Mar 24